Universal Influenza Vaccines for Humans and Animals
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 717
Special Issue Editor
Interests: influenza viruses; emerging viruses; interspecies transmission of viral pathogens; virus entry and replication; virus host-range; virus ecology and evolution
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Seasonal epidemics and occasional pandemics highlight the major public health burden of influenza virus infections in the human population. In addition, influenza outbreaks in a wide range of animal species present a threat to domestic and wild animal well-being and food security. Vaccination is universally accepted as the most effective way to prevent influenza infections. However, the ever-changing nature of these viruses, which mutate through antigenic drift and/or shift, results in escape from earlier immune responses and the need for vaccine reformulation and re-vaccination. Universal vaccine efforts tackling these challenges attempt to improve the strength and/or breadth of the immune response. Outstanding questions include how different vaccines modulate mucosal, humoral and cellular responses, the duration of immunity after vaccination, quality and/or quantity of protective immune responses and the establishment of methods to better understand correlates of protection. This Special Issue is dedicated to novel and/or improved vaccine technologies, manufacturing tools and alternative methods to measuring immune responses to establish more effective universal vaccines and universal platforms to prevent influenza infections in humans and animals. I encourage you to take advantage of this opportunity to highlight your influenza vaccine research.
Dr. Daniel R Perez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza
- universal vaccine
- correlates of protection
- adjuvant
- mass vaccination
- intranasal vaccine
- inactivated vaccine
- orthomyxovirus
- seasonal influenza
- pandemic influenza
- highly pathogenic avian influenza
- swine influenza
- equine influenza
- canine influenza
- avian influenza
- influenza host range
